Sex Differences in Clinical Course and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure

Savarese, 2017, Global public health burden of heart failure, Card Fail Rev, 3, 7, 10.15420/cfr.2016:25:2 Benjamin, 2018, Heart Disease and Stroke Statistics-2018 update: a report from the American Heart Association, Circulation, 137, e67, 10.1161/CIR.0000000000000558 2018, Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 392, 1789, 10.1016/S0140-6736(18)32279-7 Aimo, 2018, Sex-related differences in chronic heart failure, Int J Cardiol, 255, 145, 10.1016/j.ijcard.2017.10.068 Hsich, 2009, Heart failure in women: a need for prospective data, J Am Coll Cardiol, 54, 491, 10.1016/j.jacc.2009.02.066 Dewan, 2019, Differential impact of heart failure with reduced ejection fraction on men and women, J Am Coll Cardiol, 73, 29, 10.1016/j.jacc.2018.09.081 Chandra, 2019, Health-related quality of life in heart failure with preserved ejection fraction: the PARAGON-HF trial, J Am Coll Cardiol HF, 7, 862 Hernandez, 2009, Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF), Am Heart J, 157, 271, 10.1016/j.ahj.2008.07.031 O'Connor, 2011, Effect of nesiritide in patients with acute decompensated heart failure, N Engl J Med, 365, 32, 10.1056/NEJMoa1100171 1990, EuroQol - a new facility for the measurement of health-related quality of life, Health Policy, 16, 199, 10.1016/0168-8510(90)90421-9 Greene, 2017, Hospitalization for recently diagnosed versus worsening chronic heart failure: from the ASCEND-HF trial, J Am Coll Cardiol, 69, 3029, 10.1016/j.jacc.2017.04.043 Shah, 2012, Gender does not affect postdischarge outcomes in patients hospitalized for worsening heart failure with reduced ejection fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan [EVEREST] Trial), Am J Cardiol, 110, 1803, 10.1016/j.amjcard.2012.08.016 Motiejunaite, 2020, The association of long-term outcome and biological sex in patients with acute heart failure from different geographic regions, Eur Heart J, 41, 1357, 10.1093/eurheartj/ehaa071 Dewan, 2019, Sex-related differences in heart failure with preserved ejection fraction, Circ Heart Fail, 12, 10.1161/CIRCHEARTFAILURE.119.006539 Tahhan, 2018, Enrollment of older patients, women, and racial and ethnic minorities in contemporary heart failure clinical trials: a systematic review, JAMA Cardiol, 3, 1011, 10.1001/jamacardio.2018.2559 Vaduganathan, 2019, Do women and men respond similarly to therapies in contemporary heart failure clinical trials?, J Am Coll Cardiol HF, 7, 267 Hjalmarson, 2000, Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group, JAMA, 283, 1295, 10.1001/jama.283.10.1295 McMurray, 2014, Angiotensin-neprilysin inhibition versus enalapril in heart failure, N Engl J Med, 371, 993, 10.1056/NEJMoa1409077